Literature DB >> 24508914

Novel insights into G protein and G protein-coupled receptor signaling in cancer.

Morgan O'Hayre1, Maria S Degese1, J Silvio Gutkind2.   

Abstract

G protein-coupled receptors (GPCRs) play a central role in signal transmission, thereby controlling many facets of cellular function. Overwhelming evidence now implicates GPCRs, G proteins and their downstream signaling targets in cancer initiation and progression, where they can influence aberrant cell growth and survival, largely through activation of AKT/mTOR, MAPKs, and Hippo signaling pathways. GPCRs also play critical roles in the invasion and metastasis of cancer cells via activation of Rho GTPases and cytoskeletal changes, and angiogenesis to supply the tumor with nutrients and provide routes for metastasis. Lastly, GPCRs contribute to the establishment and maintenance of a permissive tumor microenvironment. Understanding GPCR involvement in cancer malignancy may help identify novel therapeutic opportunities for cancer prevention and treatment. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24508914      PMCID: PMC4021379          DOI: 10.1016/j.ceb.2014.01.005

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  91 in total

1.  Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

Authors:  E J van Corven; A Groenink; K Jalink; T Eichholtz; W H Moolenaar
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

2.  P-REX2, a novel PI-3-kinase sensitive Rac exchange factor.

Authors:  Hans Rosenfeldt; José Vázquez-Prado; J Silvio Gutkind
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

3.  Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs.

Authors:  Susanne Lutz; Aruna Shankaranarayanan; Cassandra Coco; Marc Ridilla; Mark R Nance; Christiane Vettel; Doris Baltus; Chris R Evelyn; Richard R Neubig; Thomas Wieland; John J G Tesmer
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

Review 4.  Bacterial toxins as probe for receptor-Gi coupling.

Authors:  M Ui; T Katada
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1990

5.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

Review 6.  Early signals in the mitogenic response.

Authors:  E Rozengurt
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

Review 7.  Transmembrane signalling pathways initiating cell growth in fibroblasts.

Authors:  J Pouysségur; J C Chambard; G L'Allemain; I Magnaldo; K Seuwen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-26       Impact factor: 6.237

8.  Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin.

Authors:  J C Chambard; S Paris; G L'Allemain; J Pouysségur
Journal:  Nature       Date:  1987 Apr 23-29       Impact factor: 49.962

9.  Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Authors:  Huichen Feng; Masahiro Shuda; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

Review 10.  Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.

Authors:  Morgan O'Hayre; Catherina L Salanga; Tracy M Handel; Samantha J Allen
Journal:  Biochem J       Date:  2008-02-01       Impact factor: 3.857

View more
  123 in total

Review 1.  Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Drugs       Date:  2017-06       Impact factor: 9.546

2.  Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells.

Authors:  Laurence Booth; Jane L Roberts; Cindy Sander; Alshad S Lalani; John M Kirkwood; John F Hancock; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2018-12-20       Impact factor: 4.742

3.  cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.

Authors:  María Castejón-Griñán; Cecilia Herraiz; Conchi Olivares; Celia Jiménez-Cervantes; Jose Carlos García-Borrón
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

Review 4.  The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis.

Authors:  Rohit Rao; Ralph Salloum; Mei Xin; Q Richard Lu
Journal:  Cell Cycle       Date:  2016-05-18       Impact factor: 4.534

Review 5.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 6.  Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

Authors:  Cornelia Walther; Stephen S G Ferguson
Journal:  Mol Endocrinol       Date:  2015-05-05

7.  Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.

Authors:  Ze Liu; Mandi M Hopkins; Zhihong Zhang; Chrystal B Quisenberry; Louise C Fix; Brianna M Galvan; Kathryn E Meier
Journal:  J Pharmacol Exp Ther       Date:  2014-12-09       Impact factor: 4.030

8.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

9.  Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression.

Authors:  Jianfeng Wang; Yunze Xu; Yun Zou; Liangsong Zhu; Baijun Dong; Jiwei Huang; Yonghui Chen; Wei Xue; Yiran Huang; Wen Kong; Jin Zhang
Journal:  Tumour Biol       Date:  2016-10-18

10.  Surface coatings alter transcriptional responses to silver nanoparticles following oral exposure.

Authors:  Sameera Nallanthighal; Lukas Tierney; Nathaniel C Cady; Thomas M Murray; Sridar V Chittur; Ramune Reliene
Journal:  NanoImpact       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.